Hu M Y, Cipolle M, Sielaff T, Lovdahl M J, Mann H J, Remmel R P, Cerra F B
Department of Surgery, School of Medicine, University of Minnesota, Minneapolis, USA.
Crit Care Med. 1995 Jul;23(7):1237-42. doi: 10.1097/00003246-199507000-00014.
An extracorporeal bioartificial liver device must maintain viability and differentiated function of hepatocytes cultivated at high cell density. Growth factors, such as hepatocyte growth factor, found in high concentrations in the plasma of patients with fulminant hepatic failure, have the potential to promote hepatocyte dedifferentiation and thus, decrease function. We tested the hypothesis that hepatocyte growth factor would improve viable cell density and decrease biotransformation functions of liver cells in monolayer culture and in hepatocytes entrapped in collagen cylindrical gel "noodles" as found in the extracorporeal bioartificial liver.
In vitro, controlled study.
University research laboratory.
Adult Sprague Dawley Rats.
Hepatocytes were harvested by a two-step collagenase technique. Harvested hepatocytes were plated onto type 1 collagen coated plates or entrapped in type 1 collagen cylindrical gels and cultured in different concentrations of hepatocyte growth factor. Interval measurements of 3H-thymidine incorporation, albumin synthesis, biotransformation functions, and viability were made.
In monolayer culture, the addition of hepatocyte growth factor caused a dramatic increase in 3H-thymidine incorporation. This increase was accompanied by a decrease in the appearance of the lidocaine metabolite, monoethyglycinexylidide. Albumin production was unchanged. In cylindrical gel entrapment cultures, hepatocyte growth factor caused a significant increase in 2-day viability but had no effect on the metabolite appearance of lidocaine or 4-methyl umbelliferone or albumin production.
Hepatocyte growth factor induces dedifferentiation of hepatocytes in monolayer culture. Collagen matrix entrapment appears to abrogate this effect and improve liver cell viability. There may be reciprocal regulation of hepatocyte reproductive and differentiated functions, such as biotransformation, which can be influenced by the entrapment of hepatocytes in an extracellular type 1 collagen matrix.
体外生物人工肝装置必须维持高细胞密度培养的肝细胞的活力和分化功能。在暴发性肝衰竭患者血浆中发现的高浓度生长因子,如肝细胞生长因子,有可能促进肝细胞去分化,从而降低功能。我们检验了这样一个假设:在单层培养以及体外生物人工肝中使用的包裹在胶原圆柱凝胶“面条”中的肝细胞中,肝细胞生长因子会提高活细胞密度并降低肝细胞的生物转化功能。
体外对照研究。
大学研究实验室。
成年Sprague Dawley大鼠。
采用两步胶原酶技术收获肝细胞。将收获的肝细胞接种到1型胶原包被的培养板上,或包裹在1型胶原圆柱凝胶中,并在不同浓度的肝细胞生长因子中培养。对3H-胸腺嘧啶核苷掺入、白蛋白合成、生物转化功能和活力进行间隔测量。
在单层培养中,添加肝细胞生长因子导致3H-胸腺嘧啶核苷掺入显著增加。这种增加伴随着利多卡因代谢产物单乙基甘氨酰二甲苯的出现减少。白蛋白产生未改变。在圆柱凝胶包裹培养中,肝细胞生长因子使2天的活力显著增加,但对利多卡因或4-甲基伞形酮的代谢产物出现或白蛋白产生没有影响。
肝细胞生长因子在单层培养中诱导肝细胞去分化。胶原基质包裹似乎消除了这种作用并提高了肝细胞活力。肝细胞的增殖和分化功能,如生物转化,可能存在相互调节,这可能受到肝细胞包裹在细胞外1型胶原基质中的影响。